A carregar...

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas

BACKGROUND: Fibrinogen-like protein 2 (FGL2) may promote glioblastoma multiforme (GBM) cancer development by inducing multiple immune-suppression mechanisms. METHODS: The biological significance of FGL2 expression was assessed using the The Cancer Genome Atlast (TCGA) glioma database and tumor lysat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Yan, Jun, Kong, Ling-Yuan, Hu, Jiemiao, Gabrusiewicz, Konrad, Dibra, Denada, Xia, Xueqing, Heimberger, Amy B., Li, Shulin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554195/
https://ncbi.nlm.nih.gov/pubmed/25971300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!